Companies rush to set terms before IPO window closes
This article was originally published in Scrip
Executive Summary
Biotechnology executives know that the initial public offering window is open for a limited time and it seems that companies in the crowded IPO waiting room are getting ready to squeeze through the opening in rapid succession.